The injection market is currently dominated by pen injectors for insulin delivery, but autoinjectors are becoming more common and in a broader range of indications. Each device type has pros and cons. Pen injectors allow the patient to adjust the delivered dose, critical for drugs such as insulin-requiring titration. Also, pen injectors enable multiple injections from the same drug container, reducing the cost per dose.

Digital Journal: Drug Development & Delivery

Authors: Iain Simpson, Director of Business Development, Phillips Medisize and Henrick Leisner, Envoi Platform Manager,  Phillips Medisize

September, 2024

Pages 43-44

Read the Article

View Product Pages, Blogs, and Other Resources

The Envoi Pen Injector is an important addition to the Phillips Medisize portfolio, empowering biopharma companies to accelerate the rollout of novel and generic drug treatments with significant economies of scale.

This solution provides the advantages expected from familiar pen designs, while benefiting from decades of our device development expertise and large-volume manufacturing capabilities to reduce the challenge of bringing affordable drugs and delivery devices to market. 

  • Compact form factor
  • Featuring limited elongation by dose setting
  • East of administration in case of dexterity issues
  • Fixed or variable dosing
  • Target low dosing force
Bring Your Drug Delivery Device to Life
Learn More

Advanced Medical Innovation, Design and Production

The future is rich with potential for medical technology — and a better, connected patient experience is at the center of it. Improving lives by bringing more advanced care closer to home is not only possible but emerging rapidly.

For decades, Phillips-Medisize, a Molex company, has been laser focused on contract design and manufacturing of products in highly regulated industries such as Pharmaceuticals, where precision, reliability and quality are critical.

Read What Experts Are Saying
Learn More

Exact Sciences and Phillips-Medisize Collaborate to Fight Colorectal Cancer

Exact Sciences, a leader in cancer testing, developed a game-changing at-home colorectal cancer kit, but needed support to build the highest quality product. With decades of manufacturing innovation for healthcare and life sciences companies, Exact Sciences found a quality-first collaborator in Phillips-Medisize.

Blend Innovative Science and Advanced Manufacturing
Learn More